Mvasi, a biosimilar of Avastin, is indicated to treat five types of cancer.
Specialty Pharmacy News
With the acquisition, the company said it would expand the scope of Value Specialty Pharmacy’s business while retaining the current leadership and employees of Restore Rx — and its prime location near FedEx's Memphis hub.
According to CDC data, when taken consistently, PrEP has been shown to reduce the risk of HIV infection in people who are at high risk by more than 90%.
J.D. Power’s 2017 U.S. Pharmacy Study is showing a drop in overall customer satisfaction for an industry that typically ranks among the highest-scoring ones assessed by the market research company.
Among the potential treatments Gilead will acquire is Kite’s most advanced therapy candidate, axicabtagene ciloleucel (axi-cel), a cancer-fighting therapy expected to be the first to market to treat refractory aggressive non-Hodgkin lymphoma, with a Food and Drug Administration decision date of Nov. 29.
The FDA approved Novartis' Kymriah (tisagenlecleucel) for certain pediatric and young adult patients with a form of acute lymphoblastic leukemia.
The accreditation applies to all of Supervalu’s 181 banner pharmacies that now have access to the specialty pharmacy offering, the company said.
The disease management accreditation was given for a number of Accordant’s programs providing services to patients with rare chronic disease and other conditions on behalf of health plans, government-sponsored plans, labor groups, employers and third-party administrators
WILMINGTON, Del. — AstaZeneca and Merck’s Lynzparza (olaparib) tablets were approved by the Food and Drug Administration, as well as given an expanded indication by the regulatory agency.